Nascent Biotech

(OTC) NBIO

Current Price$0.00

Market Cap$34,400

Since IPO (2014)-100%

5 Year-100%

1 Year-71%

1 Month-33%

Nascent Biotech Financials at a Glance

Market Cap

$34,400

Revenue (TTM)

$3.38

Net Income (TTM)

$1.35M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-4.65 (Low)

Dividend

$0.00

Beta (Volatility)

-4.65 (Low)

Price

$0.00

Volume

11,200

Open

$0.00

Price

$0.00

Volume

11,200

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.13

Dividend

$0.00

Beta (Volatility)

-4.65 (Low)

Price

$0.00

Volume

11,200

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.13

NBIO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nascent Biotech

Industry

Biotechnology

Sector

Health Care

CEO

Sean Carrick

Website

www.nascentbiotech.com

Headquarters

Vero Beach, FL 32960, US

NBIO Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

Return on Assets

-4%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$34.40K

Shares Outstanding

172.20M

Volume

11.20K

Avg. Volume

6.70K

Financials (TTM)

Gross Profit

$320.00K

Operating Income

$2.23M

EBITDA

$527.43K

Operating Cash Flow

$1.19M

Capital Expenditure

$4.00

Free Cash Flow

$1.19M

Cash & ST Invst.

$372.12K

Total Debt

$122.50K

Nascent Biotech Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$34.40K

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$252.00K

+69.6%

EBITDA

$251.00K

+64.3%

Quarterly Fundamentals

Name

Q2 2025YOY CHG

Net Cash

$57.18K

-108.2%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$59.00K

-80.7%

Return on Assets

-3.78%

N/A

Return on Invested Capital

8.69%

N/A

Free Cash Flow

$324.73K

-99.6%

Operating Cash Flow

$324.73K

-99.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RLBDReal Brands, Inc.

RLBDReal Brands, Inc.$0.00+0.00%

PZOOPazoo, Inc.

PZOOPazoo, Inc.$0.00+0.00%

VIVXFAvivagen Inc.

VIVXFAvivagen Inc.$0.00+0.00%

RGRXRegeneRx Biopharmaceuticals, Inc.

RGRXRegeneRx Biopharmaceuticals, Inc.$0.00+0.00%

CWWBFPlant-Based Investment Corp.

CWWBFPlant-Based Investment Corp.$0.00+0.00%

FCHSFirst Choice Healthcare Solutions, Inc.

FCHSFirst Choice Healthcare Solutions, Inc.$0.00+0.00%

BSYIBioSyntech, Inc.

BSYIBioSyntech, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

TSLATesla

TSLATesla$390.82+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About NBIO

What is the current price of Nascent Biotech?

Nascent Biotech is trading at $0.00 per share.

What is the 52-week range for Nascent Biotech?

Over the past 52 weeks, Nascent Biotech has traded between $0.00 and $0.13.

How much debt does Nascent Biotech have?

As of the most recent reporting period, Nascent Biotech reported total debt of $59,000.

How much cash does Nascent Biotech have on hand?

Nascent Biotech reported $1,822 in cash and cash equivalents in its most recent financial results.

What is Nascent Biotech’s dividend yield?

Nascent Biotech does not currently have a dividend yield.

Nascent Biotech

Nascent Biotech Financials at a Glance

NBIO News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Nascent Biotech

NBIO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Nascent Biotech Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NBIO

What is the current price of Nascent Biotech?

What is the 52-week range for Nascent Biotech?

How much debt does Nascent Biotech have?

How much cash does Nascent Biotech have on hand?

What is Nascent Biotech’s dividend yield?

Premium Investing Services